?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Biologics Price Competition and Innovation Act of 2009
The abbreviated FDA licensure pathway law